(Q43256259)

17 November 2017

title

Pharmacotherapy: Cardiovascular effects of aldosterone blockade in CKD. (English)

1 reference

17 November 2017

0 references

1

Bertram Pitt

1 reference

17 November 2017

language of work or name

English

0 references

publication date

1 November 2009

1 reference

Nature Reviews Cardiology

17 November 2017

published in

1 reference

17 November 2017

volume

6

1 reference

17 November 2017

issue

11

1 reference

17 November 2017

page(s)

679-680

1 reference

Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: a randomized controlled trial.

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.175

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.175

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.175

Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.175

Aldosterone blockade: an emerging strategy for abrogating progressive renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.175

Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.175

Mechanisms of impaired potassium handling with dual renin-angiotensin-aldosterone blockade in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.175

Drug Insight: eplerenone, a mineralocorticoid-receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.175

10.1038/NRCARDIO.2009.175

21 January 2018

Identifiers

DOI

1 reference

17 November 2017

1 reference